Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Closing

Delve into the intriguing connection between hepatic hypothyroidism and Nonalcoholic Steatohepatitis (NASH). The discussion highlights the increasing prevalence of these conditions, alongside promising liver-targeted treatments in clinical trials. Expect insights into how thyroid hormones could reshape understanding and management of fatty liver diseases. A captivating exploration of emerging medical pathways awaits!